Osteoarthritis Trial, Recruiting NCT06640764 Sponsor: Medacta International SA Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06640764
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have severe hip pain or difficulty moving due to osteoarthritis, injury-related arthritis, a hip development condition, or loss of blood supply to the hip bone, and your doctor has recommended a total hip replacement.
  • You will be receiving a specific type of hip implant called the Medacta SMS femoral stem.
  • You are willing to follow all the requirements of the study.
  • You have signed a consent form agreeing to take part.
  • You are covered by a social security system.
  • You are between 18 and 75 years old.

Who may not be able to join:

  • You are currently taking part in another medical research study.
  • You are under 18 years old.
  • You are an adult who is legally protected or considered vulnerable under French public health law (confirm with trial site).
  • You are pregnant or currently breastfeeding.
  • You are unable to express your agreement or disagreement with taking part.
  • You do not want your personal data to be collected as part of the study.
  • You have an active infection of any kind, or your bones are not yet fully developed.
  • You have a significantly unusual bone structure in the hip area, as judged by the surgeon.
  • You have a bone-softening condition (osteomalacia) that makes an uncemented implant unsuitable for you.
  • You have active rheumatoid arthritis or osteoporosis.
  • You have a metabolic condition that could affect bone healing, making an uncemented implant unsuitable for you.
  • You have muscle wasting or a neuromuscular disease.
  • You have a known allergy to the materials used in the implant.
  • You are unable or unwilling to give informed consent to take part.
  • You have other existing health conditions that could prevent you from regaining the ability to move independently after surgery.
  • You have any other reason that would prevent you from safely receiving this implant, as listed in the device's official instructions (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0033 05 61 37 85 93

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medacta International SA
Registry
ClinicalTrials.gov
Start date
1 September 2024
Est. completion
1 September 2034

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Survival rate of SMS femoral stem

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov